Concepedia

Urszula Wilczynska-Kalak

UW

Statistics

Publications

3

Citations

344

H-Index

3

Active since

2007

Affiliations

UNSW Sydney(Current)

Children's Cancer Institute Australia

Urszula Wilczynska-Kalak is an author at UNSW Sydney specializing in acute lymphoblastic leukemia treatment, oncology, and medicine.

Publications per year

2007–2012

3

Publications

3

Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo

Min H. Kang, Yun Hee Kang, Barbara Szymanska et al. · Blood · 2007 · 156 citations · Full text

Medicine, Oncology, Pharmacology +11

The Bcl-2 Homology Domain 3 Mimetic ABT-737 Targets the Apoptotic Machinery in Acute Lymphoblastic Leukemia Resulting in Synergistic in Vitro and in Vivo Interactions with Established Drugs

Laura High, Barbara Szymanska, Urszula Wilczynska-Kalak et al. · Molecular Pharmacology · 2009 · 120 citations

Medicine, Oncology, Pharmacology +17

Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts

Barbara Szymanska, Urszula Wilczynska-Kalak, Min H. Kang et al. · PLoS ONE · 2012 · 68 citations · Full text

Medicine, Oncology, Pharmacology +15

1–3 of 3